SCHEMBL5192140

SCHEMBL5192140

COCC(=O)N1CCN(c2ccnc(-n3ccnc3)n2)C(CC(=O)NC(C)c2ccc3c(c2)OCO3)C1

nearest known ligand 0.66

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5193444 0.93 NOS2 (0.68) NOS2
SCHEMBL5189733 0.93 NOS2 (0.77) NOS2
SCHEMBL5193083 0.92 NOS2 (0.57) NOS2
SCHEMBL5192691 0.92 NOS2 (0.65) NOS2
SCHEMBL5189888 0.92 NOS2 (0.57) NOS2
SCHEMBL5192525 0.92 NOS2 (0.57) NOS2
SCHEMBL5189839 0.91 NOS2 (0.69) NOS2
SCHEMBL5189763 0.89 NOS2 (0.67) NOS2
SCHEMBL5192684 0.89 NOS2 (0.53) NOS2
SCHEMBL5189922 0.88 NOS2 (0.71) NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1754703-A2 N-Heterocyclic derivatives as nos inhibitors Berlex, Inc. (US) 2007-02-21 EP claimed
EP-1754703-A2 N-Heterocyclic derivatives as nos inhibitors Berlex, Inc. (US) 2007-02-21 EP disclosed
EP-0968206-B1 N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS BERLEX LAB (US) 2006-11-15 EP disclosed